Table 3.
IC50 values and tumor specificity index.
Compounds | IC50 (µM) | Tumor specificity index | |||||
---|---|---|---|---|---|---|---|
HeLa* | HT29* | C6* | Vero* | HeLa | HT29 | C6 | |
2 | 3.64 ± 0.42 | 0.87 ± 0.09 | 0.95 ± 0.09 | 2.81 ± 0.32 | 0.77 | 3.23 | 2.96 |
3 | 3.19 ± 0.37 | 2.37 ± 0.32 | 3.34 ± 0.34 | 3.06 ± 0.35 | 0.96 | 1.29 | 0.92 |
4 | 0.61 ± 0.09 | 0.48 ± 0.08 | 0.60 ± 0.09 | 0.63 ± 0.09 | 1.03 | 1.31 | 1.05 |
5FU | 275.68 ± 17 | 258.46 ± 21 | 217.48 ± 19 | 258.46 ± 21 | 0.94 | 1.00 | 1.19 |
Cisplatin | 230.41 ± 15 | 152.57 ± 14 | 207.51 ± 23 | 234.83 ± 19 | 1.02 | 1.54 | 1.13 |
[Ag(CN)2]¯ | 5.13 ± 0.87 | 5.18 ± 0.93 | 5.08 ± 0.89 | 5.63 ± 0.96 | 1.10 | 1.09 | 1.11 |
*Values are given as the mean ± SD of three experiments and r2 = 0.91 to 0.98. Significant at P < 0.05.